tough spin price transpar
thesi updat frankli bit confus henri schein
share nearli trade ebitda
toward high end histor rang despit
acknowledg margin run behind plan fy
price face challeng on-line transpar north
america aka amazon understand enthusiasm vet
spin ebitda appear impli valuat would
argu today best case furthermor suggest base must
trade seem punchi busi experienc potenti
margin degrad structur issu overcom long
term name neg client mix shift on-line competit thu
understand posit matter still surpris
st complet ignor new develop ultim
wonder compani remark well run share
approach near peak valu mind given enthusiasm spin
pt move current trade expect
revers share upcom week stock like see
exagger bounc given short base fundament think
 justifi long term bear case anyth
north american dental consum organ growth
highest quarterli growth rate sinc
cad/cam sale continu robust north america
quarter
implant grew organ compani expect
busi continu profit time expect
strateg addit platform near futur
tech equip sale primarili due higher market penetr
compani continu see price pressur on-line retail
continu grow offer open price
exclud restructur cost transact cost relat plan
anim health spin prior year litig cost oper
margin quarter still contract around bp yoy primarili
driven lower gross margin north america
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
chang
ep rais vs prior
oper margin neg impact primarili lower gross margin north america
 restructur cost transact cost relat plan anim health spin-off prior year includ litig
neg impact yoy comparison bp
 work increas sale higher margin product drive gm improv
 impact consum merchandis sale growth relat good friday immateri bp
 dental intern growth favor impact due time friday
 normal impact manufactur switch direct agenc agreement sale growth
 compani believ dd normal sale growth reflect healthi end market
 saw littl bit help warm client part countri
 sale driven solid organ growth exist larg custom
 sale saw dd growth financi servic dental softwar revenu
 continu add addit bundl practic manag solut
 bundl softwar solut sme specialti dental practic
mm remain futur repurchas
look opportun augment technolog solut gener effici particularli redund activ result
prior acquisit
headcount reduct may also includ consolid certain warehous activ
expect record one-tim restructur charg mm mm pre-tax basi
 charg primarili includ sever pay facil close cost outsid profession consult fee directli relat
restrict plan
track spin-off effort
work close end possibl may slip
henri schein stat million except per share data fy end septemb dental anim health medic organ gp growth revenu margin bp ebit growth gross profit ep share net incom price-to-earnings premium/discount isi healthcar technolog distribut august
valuat price target base dcf methodolog contempl wacc termin
ebitda multipl equat perpetu growth rate pt translat ebitda vs
yr average
downsid risk potenti na consum trend remain subdu util anem impact
hdp crowd demand increas competit on-line channel notabl extend beyond basic consum
broader spectrum product price dental channel increasingli challeng dso competit heat defend
share ultim pressur om volatil fx rate depress medium-term profit trajectori complic effort
expand oper margin elev valuat broadli could slow derail manag strategi pursu consist tuck-
acquisit global competit dental equip market intensifi post key contract chang purchas
delay purchas high end
laboratori corp america hold
articl articl
time dissemin august et
analyst ross muken elizabeth anderson suzi yoon primarili respons prepar research report attest
follow view opinion render research report reflect person view subject compani issuer
part research analyst compens directli relat specif recommend view
